Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

299 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Genetic polymorphisms of enzyme proteins and transporters related to methotrexate response and pharmacokinetics in a Japanese population.
Hashiguchi M, Shimizu M, Hakamata J, Tsuru T, Tanaka T, Suzaki M, Miyawaki K, Chiyoda T, Takeuchi O, Hiratsuka J, Irie S, Maruyama J, Mochizuki M. Hashiguchi M, et al. Among authors: tsuru t. J Pharm Health Care Sci. 2016 Dec 9;2:35. doi: 10.1186/s40780-016-0069-0. eCollection 2016. J Pharm Health Care Sci. 2016. PMID: 27980801 Free PMC article.
Mechanism-based approach using a biomarker response to evaluate tocilizumab subcutaneous injection in patients with rheumatoid arthritis with an inadequate response to synthetic DMARDs (MATSURI study).
Ohta S, Tsuru T, Terao K, Mogi S, Suzaki M, Shono E, Ishida Y, Tarumi E, Imai M. Ohta S, et al. Among authors: tsuru t. J Clin Pharmacol. 2014 Jan;54(1):109-19. doi: 10.1002/jcph.185. Epub 2013 Oct 12. J Clin Pharmacol. 2014. PMID: 24115082 Free PMC article. Clinical Trial.
SARS-CoV-2 Seroprevalence among Healthcare Workers in General Hospitals and Clinics in Japan.
Yoshihara T, Ito K, Zaitsu M, Chung E, Aoyagi I, Kaji Y, Tsuru T, Yonemura T, Yamaguchi K, Nakayama S, Tanaka Y, Yurino N, Koyanagi H, Matsuki S, Urae R, Irie S. Yoshihara T, et al. Among authors: tsuru t. Int J Environ Res Public Health. 2021 Apr 5;18(7):3786. doi: 10.3390/ijerph18073786. Int J Environ Res Public Health. 2021. PMID: 33916399 Free PMC article.
Treatment selection in the clinical practice of systemic lupus erythematosus: results from the Kyushu Collagen Disease Network for Systemic Lupus Erythematosus (KCDN-SLE) registry.
Ayano M, Ueda N, Mishima K, Ota SI, Kushimoto K, Tanaka A, Kawano S, Nishimura N, Kashiwado Y, Doi G, Nakayama T, Fukumoto R, Tsuru T, Suzaki M, Akahoshi M, Maekawa M, Omoto A, Tada H, Akashi K, Horiuchi T, Niiro H. Ayano M, et al. Among authors: tsuru t. Mod Rheumatol. 2024 Aug 3:roae058. doi: 10.1093/mr/roae058. Online ahead of print. Mod Rheumatol. 2024. PMID: 39096517
Comparison of immunogenicity between candidate influenza A(H3N2) virus vaccine strains in Japan: A randomized controlled trial using a monovalent vaccine of A/Saitama/103/2014 (CEXP-002) and A/Hong Kong/4801/2014 (X-263).
Kase T, Inoue M, Morikawa S, Kumashiro H, Hiroi S, Nakata K, Ito K, Ishibashi M, Tsuru T, Irie S, Maeda A, Ohfuji S, Fukushima W, Hirota Y. Kase T, et al. Among authors: tsuru t. Vaccine. 2020 Sep 29;38(42):6524-6532. doi: 10.1016/j.vaccine.2020.08.025. Epub 2020 Aug 29. Vaccine. 2020. PMID: 32873406 Free article. Clinical Trial.
Safety and efficacy of combination therapy of iguratimod with methotrexate for patients with active rheumatoid arthritis with an inadequate response to methotrexate: an open-label extension of a randomized, double-blind, placebo-controlled trial.
Hara M, Ishiguro N, Katayama K, Kondo M, Sumida T, Mimori T, Soen S, Nagai K, Yamaguchi T, Yamamoto K; Iguratimod-Clinical Study Group. Hara M, et al. Mod Rheumatol. 2014 May;24(3):410-8. doi: 10.3109/14397595.2013.843756. Epub 2013 Nov 7. Mod Rheumatol. 2014. PMID: 24252050 Clinical Trial.
299 results